LEX CANNA

FDA’s Position on CBD and Public Hearing

2019 has been the year of the cannabidiol (“CBD”). CBD-infused beverages, food, and cosmetics products are becoming mainstream commodities that are flying off the shelves.  The CBD craze exploded after Congress passed the Farm Bill in late 2018, despite the fact that the passage of the legislation has not legalized many of the CBD-infused products […]

U.S. Trademark Office Issues Cannabis Registration Guidance

On May 2, 2019 the USPTO released its Examination Guide 1-19, Examination of Marks for Cannabis and Cannabis-Related Goods and Services after Enactment of the 2018 Farm Bill (here: https://www.uspto.gov/sites/default/files/documents/Exam%20Guide%201-19.pdf) , which aims to clarify the procedure for examining marks for cannabis and cannabis-derived goods and for services involving cannabis and cannabis production following the […]

New California Cannabis Regulations Create Uncertainty For Corporate Owners

On October 19, 2018 California’s three state cannabis licensing authorities published proposed changes to the forthcoming state rules governing the cannabis industry.  While there are numerous revisions that will impact operators, one provision of the changes stands out for investors in the cannabis space. Previous iterations of the cannabis regulations required limited disclosure of merely […]

« Older Entries